Follow
Jacques Fellay
Jacques Fellay
EPFL / CHUV
Verified email at epfl.ch - Homepage
Title
Cited by
Cited by
Year
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
D Ge, J Fellay, AJ Thompson, JS Simon, KV Shianna, TJ Urban, ...
Nature 461 (7262), 399-401, 2009
45612009
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ...
Science 370 (6515), eabd4570, 2020
22772020
A whole-genome association study of major determinants for host control of HIV-1
J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ...
science 317 (5840), 944-947, 2007
15262007
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus
AJ Thompson, AJ Muir, MS Sulkowski, D Ge, J Fellay, KV Shianna, ...
Gastroenterology 139 (1), 120-129. e18, 2010
9712010
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
J Fellay, C Marzolini, ER Meaden, DJ Back, T Buclin, JP Chave, ...
The Lancet 359 (9300), 30-36, 2002
8482002
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation
S Marcel, AL Christian, N Richard, S Silvia, H Emma, F Jacques, Z Marcel, ...
Swiss medical weekly 150, w202205, 2020
6242020
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
J Fellay, AJ Thompson, D Ge, CE Gumbs, TJ Urban, KV Shianna, LD Little, ...
Nature 464 (7287), 405-408, 2010
5542010
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
5042021
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
J Fellay, B Ledergerber, E Bernasconi, H Furrer, M Battegay, B Hirschel, ...
The Lancet 358 (9290), 1322-1327, 2001
4912001
Common genetic variation and the control of HIV-1 in humans
J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ...
PLoS genetics 5 (12), e1000791, 2009
4812009
IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C
TJ Urban, AJ Thompson, SS Bradrick, J Fellay, D Schuppan, KD Cronin, ...
Hepatology 52 (6), 1888-1896, 2010
4652010
A global scientific strategy to cure hepatitis B
PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ...
The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019
4582019
Influence of HLA-C expression level on HIV control
R Apps, Y Qi, JM Carlson, H Chen, X Gao, R Thomas, Y Yuki, ...
Science 340 (6128), 87-91, 2013
4162013
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3692021
Privacy in the genomic era
M Naveed, E Ayday, EW Clayton, J Fellay, CA Gunter, JP Hubaux, ...
ACM Computing Surveys (CSUR) 48 (1), 1-44, 2015
3482015
Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection
C Csajka, C Marzolini, K Fattinger, LA Décosterd, J Fellay, A Telenti, ...
Clinical pharmacology & therapeutics 73 (1), 20-30, 2003
3472003
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C
R Thomas, R Apps, Y Qi, X Gao, V Male, C O'huigin, G O'Connor, D Ge, ...
Nature genetics 41 (12), 1290-1294, 2009
3332009
Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors
E Patin, M Hasan, J Bergstedt, V Rouilly, V Libri, A Urrutia, C Alanio, ...
Nature immunology 19 (3), 302-314, 2018
2782018
A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection
JL Casanova, HC Su, L Abel, A Aiuti, S Almuhsen, AA Arias, P Bastard, ...
Cell 181 (6), 1194-1199, 2020
2632020
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction
AJ Thompson, J Fellay, K Patel, HL Tillmann, S Naggie, D Ge, TJ Urban, ...
Gastroenterology 139 (4), 1181-1189. e2, 2010
2272010
The system can't perform the operation now. Try again later.
Articles 1–20